<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection: Coleção voltada para a inserção de documentos dos diretores e ex-diretores do Hospital do Câncer III (Vila Isabel).</title>
  <link rel="alternate" href="https://ninho.inca.gov.br/jspui/handle/123456789/2216" />
  <subtitle>Coleção voltada para a inserção de documentos dos diretores e ex-diretores do Hospital do Câncer III (Vila Isabel).</subtitle>
  <id>https://ninho.inca.gov.br/jspui/handle/123456789/2216</id>
  <updated>2026-04-04T09:29:32Z</updated>
  <dc:date>2026-04-04T09:29:32Z</dc:date>
  <entry>
    <title>Sarcoma de Mama</title>
    <link rel="alternate" href="https://ninho.inca.gov.br/jspui/handle/123456789/2254" />
    <author>
      <name>Carmo, Pedro Aurélio Ormonde de</name>
    </author>
    <id>https://ninho.inca.gov.br/jspui/handle/123456789/2254</id>
    <updated>2021-07-15T14:12:20Z</updated>
    <published>1997-01-01T00:00:00Z</published>
    <summary type="text">Title: Sarcoma de Mama
Authors: Carmo, Pedro Aurélio Ormonde de
Abstract: Sarcoma de mama representa 1% dos canceres maligno primários. Realizamos esse estudo com 16 pacientes com sarcoma verdadeiro de mama</summary>
    <dc:date>1997-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Terapêutica das Displasias Mamárias com uma Associação de Vitaminas A, E e B6</title>
    <link rel="alternate" href="https://ninho.inca.gov.br/jspui/handle/123456789/2253" />
    <author>
      <name>Carmo, Pedro Aurélio Ormonde de</name>
    </author>
    <id>https://ninho.inca.gov.br/jspui/handle/123456789/2253</id>
    <updated>2021-07-15T12:57:27Z</updated>
    <published>1986-01-01T00:00:00Z</published>
    <summary type="text">Title: Terapêutica das Displasias Mamárias com uma Associação de Vitaminas A, E e B6
Authors: Carmo, Pedro Aurélio Ormonde de</summary>
    <dc:date>1986-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Impact of treatment type on overall survival in elderly brazilian women with breast cancer</title>
    <link rel="alternate" href="https://ninho.inca.gov.br/jspui/handle/123456789/2250" />
    <author>
      <name>Bello, Marcelo Adeodato</name>
    </author>
    <author>
      <name>Menezes, Raquel Ferreira de</name>
    </author>
    <author>
      <name>Silva, Brunna de Sousa</name>
    </author>
    <author>
      <name>Silva, Rafael de Carvalho da</name>
    </author>
    <author>
      <name>Cavalcanti, Rousiane Silva</name>
    </author>
    <author>
      <name>Moraes, Thayane de Fátima da Costa</name>
    </author>
    <author>
      <name>Tonellotto, Fabiana</name>
    </author>
    <author>
      <name>Aguiar, Suzana Sales de</name>
    </author>
    <author>
      <name>Martucci, Renata Brum</name>
    </author>
    <author>
      <name>Bergmann, Anke</name>
    </author>
    <author>
      <name>Thuler, Luiz Claudio Santos</name>
    </author>
    <id>https://ninho.inca.gov.br/jspui/handle/123456789/2250</id>
    <updated>2024-11-25T13:25:59Z</updated>
    <published>2016-01-01T00:00:00Z</published>
    <summary type="text">Title: Impact of treatment type on overall survival in elderly brazilian women with breast cancer
Authors: Bello, Marcelo Adeodato; Menezes, Raquel Ferreira de; Silva, Brunna de Sousa; Silva, Rafael de Carvalho da; Cavalcanti, Rousiane Silva; Moraes, Thayane de Fátima da Costa; Tonellotto, Fabiana; Aguiar, Suzana Sales de; Martucci, Renata Brum; Bergmann, Anke; Thuler, Luiz Claudio Santos
Abstract: Objective: To analyze the survival of elderly patients with breast cancer according to the type of treatment used. Methods: A cohort study of women aged 80 or over with breast cancer registered with the Brazilian National Cancer Institute (Instituto Nacional do Câncer -  INCA) between 2008 and 2009 was conducted. Prognosis was analyzed according to the cancer treatment performed: surgery, radiotherapy, or hormone therapy. Analysis of the overall 5-year survival rate was performed using the Kaplan - Meier method, and comparisons of curves were undertaken using the log-rank test. For multiple regression analysis, Cox regression was used, adjusting for age and clinical stage, considering values of p &lt; 0.05 as significant. Data were all analyzed using the statistical package SPSS version 20. Results: 70 women with a mean age of 84.0 ± 3.7 years at diagnosis participated in the study. The median follow-up time was 37.1 months (range 0.5–75.5), and 31 deaths (44.3%) occurred during this time. The median survival time was 51.2 months (95% CI, 44.9–57.4), higher in those who underwent surgery (p = 0.012) and those who had hormone therapy (p=0.001). Treatment with surgery reduced the risk of death by 61.7% (HR 0.3; 95% CI, 0.1–0.6; p = 0.001) when adjusted for clinical stage and age at diagnosis. However, there was no significant benefit from radiotherapy (HR 1.2; 95% CI, 0.5–2.5; p = 0.694). Conclusion: Treatment with surgery and hormone therapy increased the survival of our Brazilian patients with breast cancer aged 80 or over.</summary>
    <dc:date>2016-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Lymphatic/vascular invasion has a negative impact on overall survival and disease-free survival in patients with breast cancer and positive axillary lymph nodes</title>
    <link rel="alternate" href="https://ninho.inca.gov.br/jspui/handle/123456789/2249" />
    <author>
      <name>Bello, Marcelo Adeodato</name>
    </author>
    <id>https://ninho.inca.gov.br/jspui/handle/123456789/2249</id>
    <updated>2021-07-15T13:52:48Z</updated>
    <published>2020-04-15T00:00:00Z</published>
    <summary type="text">Title: Lymphatic/vascular invasion has a negative impact on overall survival and disease-free survival in patients with breast cancer and positive axillary lymph nodes
Authors: Bello, Marcelo Adeodato</summary>
    <dc:date>2020-04-15T00:00:00Z</dc:date>
  </entry>
</feed>

